Manager, R&D Operations
Director, Investor Relations and Communications
As Director of Investor Relations and Communications, Kelly plays a pivotal role in ensuring Psy maintains strong relationships with its investors while effectively communicating Psy’s compelling mission and vision to the broader community.
Prior to joining Psy, Kelly led brand and digital strategy for healthcare clients at Closerlook, a member of Fishawack Health, and Wunderman Thompson. Her experience includes developing and executing comprehensive marketing strategies for pharmaceutical brands at various stages of product lifecycle management. Kelly’s unwavering dedication to enhancing treatments for psychiatric and neurodegenerative disorders is driven by her deep compassion for patients and their families.
Kelly received her BA in History of Art and Corporate Strategy from Vanderbilt University. She is nearing completion of her MBA with a concentration in Health Sector Management from Boston University Questrom School of Business.